AR vs In Person Simulation for Medical Workplace Training
The Physiologic and Emotional Effects of Augmented Reality Simulation Versus In Person Simulation - A Noninferiority, Randomized Controlled Trial
1 other identifier
interventional
111
1 country
1
Brief Summary
This study will evaluate the physiologic and emotional effects of an augmented reality (AR) simulation versus an in-person simulation. This is a single institution, non-inferiority, randomized controlled trial. The target enrollment will be 100 participants in each group for a total of 200 participants. One group will wear an AR headset and participate in an AR medical crisis scenario and the other group will participate in the same scenario with a traditional, mannequin based in situ simulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 6, 2023
CompletedStudy Start
First participant enrolled
March 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2023
CompletedJanuary 2, 2024
December 1, 2023
2 days
December 21, 2022
December 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Parasympathetic response indexed by RSA
Measured via respiratory sinus arrhythmia (RSA) in hertz using chest biometric sensors in 30-second epochs.
Duration of simulation (15-20 minutes)
Secondary Outcomes (4)
Sytem Usability Scale (SUS)
Post-simulation (5 minutes)
ISO 9241-400
Post-simulation (5 minutes)
Simulation Design Scale (SDS)
Post-simulation (5-10 minutes)
Learning effectiveness
5 months-post simulation (5 minutes)
Study Arms (2)
Augmented Reality Enhanced Simulation (Treatment group)
EXPERIMENTALParticipants will experience augmented simulations with a holographic mixed-reality setting based on different workplace scenarios such as medical error and workplace harassment via Augmented Reality (AR) headset.
Traditional In Situ Simulation (Control group)
NO INTERVENTIONParticipants will experience in-person simulations of different workplace scenarios such as medical error and workplace harassment
Interventions
Augmented simulation of workplace-related scenarios of pre-recorded videos using the same actors
Eligibility Criteria
You may qualify if:
- Hospital providers, including nurses, physician assistants, physicians, physician trainees, and other healthcare workers at Lucile Packard Children's Hospital (LPCH) and affiliated facilities who communicate with patients daily will be included
You may not qualify if:
- Participants with reported severe motion sickness
- Nausea
- Seizure disorder
- Currently using chronotropic heart medications, such as β blockers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lucile Packard Children's Hospital Stanford
Palo Alto, California, 94304, United States
Related Publications (1)
Rama A, Rojas-Pino MS, Wang EY, Rodriguez ST, Suen MY, Titzler JS, Zuniga-Hernandez M, Jackson C, Rosales O, Collins F, Caruso TJ. The Physiologic Effect of Augmented Reality Simulation Versus Traditional Simulation: A Noninferiority, Randomized Controlled Trial. J Educ Perioper Med. 2025 Apr 8;27(1):E740. doi: 10.46374/VolXXVII_Issue1_Rama. eCollection 2025 Jan-Mar.
PMID: 40207076DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas J Caruso, MD, MEd
clinical professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 6, 2023
Study Start
March 20, 2023
Primary Completion
March 22, 2023
Study Completion
March 22, 2023
Last Updated
January 2, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share